Sling Therapeutics
Focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED).
12 employees · est. 2020 · Ann Arbor, United States
Side-by-Side Comparison
| Metric | Renasant Bio | Sling Therapeutics |
|---|---|---|
| Founded | ||
| Founded | Not tracked yet | 2020 |
| Headquarters | ||
| Headquarters | Berkeley, United States | Ann Arbor, United States |
| Employees | ||
| Employees | 33 | 12 |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Seed | Series A |
| Total Funding | ||
| Total Funding | $54.50M | $35.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 1 |
| Services | ||
| Services | Development of small molecule correctors and potentiators, Restoration of PC1/2 protein function, Disease-modifying therapy development for ADPKD | Development of Linsitinib for Thyroid Eye Disease, Conducting Clinical Trials, Therapeutic Pipeline Development, Medical Research and Innovation |
| Target Customers | ||
| Target Customers | Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), Biopharma researchers, Healthcare providers specializing in renal diseases | Patients with Thyroid Eye Disease, Caregivers, Healthcare Providers, Medical Researchers |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, ADPKD Treatment, Disease-Modifying Therapies, Oral Small Molecules, Genetic Disease, End-Stage Renal Failure, Protein Function Restoration, Drug Development, Polycystic Kidney Disease, Biomedical Innovation, Small Molecule Correctors, Small Molecule Potentiators | Thyroid Eye Disease, Biopharmaceutical, Clinical-stage Development, Oral Small Molecule, Drug Development, Autoimmune Diseases, Endocrinology, Ophthalmology, Hyperthyroidism, Clinical Research, Molecular Engineering, Chemistry, Patient Advocacy, Graves' Disease |
| Website | ||
| Website | renasantbio.com | slingtx.com |
About Renasant Bio
Renasant Bio, with its slogan "Transforming the Treatment of ADPKD," is making significant strides in the Biotechnology sector. The company is dedicated to developing disease-modifying oral small molecule treatments specifically for autosomal dominant polycystic kidney disease (ADPKD), a leading gen...
About Sling Therapeutics
Sling Therapeutics, a clinical-stage company founded in 2020, is making significant strides in the biopharma and biotechnology industries. The company is headquartered in the United States and focuses on the late-stage development of an oral small molecule designed to treat thyroid eye disease (TED)...
We will tell you when either one moves
BounceWatch watches Renasant Bio and Sling Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Renasant Bio and Sling Therapeutics — by email.
Frequently Asked Questions
Compare Renasant Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Renasant Bio on 9 Jun 2026, and Sling Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
